• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yamaji Kenzaburo  山地 賢三郎

ORCIDConnect your ORCID iD *help
… Alternative Names

YAMAJI Kenzaburo  山地 賢三郎

Less
Researcher Number 40508628
Affiliation (Current) 2026: 公益財団法人東京都医学総合研究所, 感染症医学研究センター, 研究員
Affiliation (based on the past Project Information) *help 2020 – 2022: 公益財団法人東京都医学総合研究所, 疾患制御研究分野, 主任研究員
2018 – 2019: 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 研究員
2017: 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 主任研究員
Review Section/Research Field
Principal Investigator
Basic Section 47040:Pharmacology-related / General pharmacology
Keywords
Principal Investigator
Wnt/β-カテニン/CBPシグナル阻害剤 / NASH / β-カテニン/CBPシグナル阻害剤 / 肝線維化 / 非アルコール性脂肪肝炎 / 肝細胞機能正常化 / 肝機能改善 / マクロファージ / 肝線維症 / wnt/beta-カテニン/CBP … More / 非アルコール性脂肪肝炎 (NASH) / PRI-724 / 脱線維化作用 / 脱線維化 Less
  • Research Projects

    (2 results)
  • Research Products

    (12 results)
  • Co-Researchers

    (1 People)
  •  Analysis of mechanism by which a Wnt/beta-catenin signaling inhibitor ameliomates NASH-induced liver fibrosis and disorderPrincipal Investigator

    • Principal Investigator
      YAMAJI Kenzaburo
    • Project Period (FY)
      2019 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 47040:Pharmacology-related
    • Research Institution
      Tokyo Metropolitan Institute of Medical Science
  •  Analysis of mechanism by which a Wnt/beta-catenin/CBP signaling inhibitor ameliomates NASH-induced liver fibrosisPrincipal Investigator

    • Principal Investigator
      YAMAJI Kenzaburo
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      General pharmacology
    • Research Institution
      Tokyo Metropolitan Institute of Medical Science

All 2022 2021 2019 2018 2017

All Journal Article Presentation

  • [Journal Article] Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease2022

    • Author(s)
      Kimura Masamichi、Nishikawa Koji、Osawa Yosuke、Imamura Jun、Yamaji Kenzaburo、Harada Kenichi、Yatsuhashi Hiroshi、Murata Kazumoto、Miura Kouichi、Tanaka Atsushi、Kanto Tatsuya、Kohara Michinori、Kamisawa Terumi、Kimura Kiminori
    • Journal Title

      Hepatology Communications

      Volume: 6 Issue: 10 Pages: 2732-2747

    • DOI

      10.1002/hep4.2043

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K06981, KAKENHI-PROJECT-22K07991, KAKENHI-PROJECT-22K08091, KAKENHI-PROJECT-19K07115
  • [Journal Article] Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model2017

    • Author(s)
      Yuko Tokunaga, Yosuke Osawa, Takahiro Ohtsuki, Yukiko Hayashi, Kenzaburo Yamaji, Daisuke Yamane, Mitsuko Hara, Keisuke Munekata, Kyoko Tsukiyama-Kohara, Tsunekazu Hishima, Soichi Kojima, Kiminori Kimura, and *Michinori Kohara
    • Journal Title

      Scientific Reports

      Volume: 7 Issue: 1 Pages: 325-325

    • DOI

      10.1038/s41598-017-00282-w

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PUBLICLY-15H01272, KAKENHI-PROJECT-15H04739, KAKENHI-PROJECT-26460965, KAKENHI-PROJECT-26860312, KAKENHI-PROJECT-16K18467, KAKENHI-PROJECT-17K15584, KAKENHI-PROJECT-15K15146
  • [Presentation] A CBP/β-catenin signaling inhibitor, PRI-724 ameliorates NASH-induced liver fibrosis and disorder2022

    • Author(s)
      Kenzaburo Yamaji, Yuko Tokunaga, Sadahiro Iwabuchi, Shinichi Hashimoto, Daisuke Yamane, Sakiko Toyama, Bouchra Kitab, Kiminori Kimura, Kyoko Tsukiyama-Kohara, Michinori Kohara
    • Organizer
      AASLD The Liver Meeting 2022
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K07115
  • [Presentation] NASH肝線維化マウスに対するβ-catenin/CBP選択的阻害剤PRI-724の脱線維化に寄与する細胞集団の同定2021

    • Author(s)
      山地賢三郎、徳永優子、岩淵禎弘、山根大典、橋本真一、小原道法
    • Organizer
      第28回肝細胞研究会
    • Data Source
      KAKENHI-PROJECT-19K07115
  • [Presentation] A CBP/β-catenin signaling inhibitor, PRI-724, improves NASH-induced liver fibrosis and disorder2019

    • Author(s)
      Kenzaburo Yamaji, Yuko Tokunaga, Daisuke Yamane, Bouchra Kitab, Yosuke Osawa, Kiminori Kimura, Chise Tateno, Yoichiro Hirose, Kyoko Tsukiyama-Kohara, Michinori Kohara
    • Organizer
      米国肝臓学会 (AASLD) 2019
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K15584
  • [Presentation] A CBP/β-catenin signaling inhibitor, PRI-724, improves NASH-induced liver fibrosis and disorder2019

    • Author(s)
      Kenzaburo Yamaji, Yuko Tokunaga, Daisuke Yamane, Bouchra Kitab, Yosuke Osawa, Kiminori Kimura, Chise Tateno, Yoichiro Hirose Kyoko Tsukiyama-Kohara, Michinori Kohara
    • Organizer
      AASLD2019
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K07115
  • [Presentation] CBP/β-catenin signaling inhibitor improved NASH-induced liver fibrosis and disorder2019

    • Author(s)
      Kenzaburo Yamaji, Yuko Tokunaga, Daisuke Yamane, Bouchra Kitab, Kiminori Kimura, Chise Tateno, Kyoko Tsukiyama-Kohara, Michinori Kohara
    • Organizer
      Liver, Biology, Diseases & Cancer 2019
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K07115
  • [Presentation] CBP/β-catenin signaling inhibitor improved NASH-induced liver fibrosis and disorder2019

    • Author(s)
      Kenzaburo Yamaji, Yuko Tokunaga, Daisuke Yamane, Bouchra Kitab, Kiminori Kimura, Chise Tateno, Kyoko Tsukiyama-Kohara, Michinori Kohara
    • Organizer
      Liver, Biology, Diseases & Cancer 2019
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K15584
  • [Presentation] Intermittent administration of selective Wnt/β-catenin/CBP signaling inhibitor ameliorates hepatitis C virus-induced liver fibrosis2018

    • Author(s)
      Yuko Tokunaga, Kiminori Kimura, Kenzaburo Yamaji, Takahiro Ohtsuki, Yukiko Hayashi, Tsunekazu Hishima, Michinori Kohara
    • Organizer
      HCV2018: 25th International Symposium on Hepatitis C Virus and Related Viruses
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K15584
  • [Presentation] PRI-724, a selective inhibitor of Wnt/β-catenin/CBP signaling, ameliomates NASH-induced liver fibrosis2018

    • Author(s)
      Kenzaburo Yamaji, Yuko Tokunaga, Takahiro Ohtsuki, Yosuke Osawa, Kiminori Kimura, Go Sugawara, Yuji Ishida, Chise Tateno, Yoichiro Hirose, Yukiko Hayashi, Tsunekazu Hishima, Michinori Kohara
    • Organizer
      AASLD The Liver Meeting 2018
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K15584
  • [Presentation] Wnt/β-catenin/CBPシグナル阻害剤PRI-724はNASHによる肝線維を消失させる.2017

    • Author(s)
      山地賢三郎、徳永優子、大槻貴博、大澤陽介、木村公則、小原道法
    • Organizer
      第53回日本肝臓学会総会
    • Data Source
      KAKENHI-PROJECT-17K15584
  • [Presentation] Heterologous prime-boost接種法によるC型肝炎ウイルス治療ワクチン効果の解析2017

    • Author(s)
      大槻貴博、塩釜ゆみ子、徳永優子、山地賢三郎、保富康宏、小原道法
    • Organizer
      第21回日本ワクチン学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K15584
  • 1.  小原 道法
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi